AGENDA OF THE 3rd ANNUAL BIOSIMILARS FORUM (OCT, 2018)

At this 3-day series of events we focused on the most actual issues and challenges in bio- and nanosimilar drug development with a strong focus on STATISTICAL and REGULATORY perspectives.

COURSE DAY

25 OCT, 2018

with 2 professional course sessions on statistical and  pharmacokinetical aspects of biosimilarity assessment (delivered by prominent biosimilar research expert scientists).

SYMPOSIUM DAY

26 OCT, 2018

with invited professional presentations, posters and round table session, was focusing on statistical and regulatory perspectives in bio- and nanosimilar development (presented by leading experts from the fields of regulatory, academic and clinical research).

SEMINAR DAY in Nanomedicines

27 OCT, 2018

NEW IN 2018: the 3rd-day programme consisted of professional Seminar sessions regarding current perspectives of bio- and nanosimilar drug development (it was lectured by special international experts from the field of nanotechnology-formulated drug research).

27th OCTOBER, 2018

3rd day: SEMINARS in Nanomedicines

9:00 – 9:30 

3rd Day Registration (for those attending only day 3)

9:30 – 12:30

MORNING SEMINAR SESSION:
The Era of Biosimilars and Nanosimilars: Current Perspectives

Raj BAWA
President of Bawa Biotech LLC; Scientific Advisor at Teva Pharmaceutical Industries, Israel; Founding Director of American Society for Nanomedicine; Editor-in-Chief of the Handbook of Clinical Nanomedicine: Nanoparticles, Imaging, Therapy, and Clinical Applications, (CRC Press, 2016); USA

Schedule of the Seminar:
  9:30 – 10:30   |   1st part of Seminar
10:30 – 11:00   |   Coffee break: refreshments & networking
11:00 – 12:30   |   2nd part of Seminar

12:30 – 13:30 

Lunch break

13:30 – 14:15

The immunological characterization of nanotechnology-formulated drugs

Marina A. DOBROVOLSKAIA,
Senior Principal Scientist and Head of the Immunology Section at the Nanotechnology Characterization Laboratory, USA

14:15 – 14:30 

Coffee break: refreshments & networking

14:30 – 15:15

Targeted Nanomedicine: State of Art and Future Developments

Gert STORM,
Professor of Targeted Nanomedicine at the University of Utrecht; Professor of Targeted Therapeutics at the MIRA Institute of the University of Twente; The Netherlands

15:15 – 15:30 

Coffee break: refreshments & networking

15:30 – 16:30

Panel discussion:

Moderator:
János SZEBENI,
Director of the Nanomedicine Research and Education Center of Semmelweis Medical University, Budapest, Hungary

Panel members:

Raj BAWA,
President of Bawa Biotech LLC; Scientific Advisor at Teva Pharmaceutical Industries, Israel; Founding Director of American Society for Nanomedicine; USA
Gert STORM,
Professor of Targeted Nanomedicine at the University of Utrecht; Professor of Targeted Therapeutics at the MIRA Institute of the University of Twente; The Netherlands